Gouty Arthritis Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Factors Are Propelling the Market Growth of theGouty Arthritis Market from 2025 to 2034?
The escalating rates of obesity are anticipated to fuel the expansion of the gouty arthritis market. Obesity, a health condition marked by an unhealthy accumulation of fat in the body, endangers an individual’s well-being and is often assessed using the body mass index (BMI). The prevalence of obesity is surging due to an increased intake of high-calorie, processed foods and inactive lifestyles. Obesity can lead to gouty arthritis by boosting uric acid production and hampering the body’s capacity to eliminate it, resulting in the build-up of uric acid crystals in the joints. Moreover, the additional body weight subjects joints to more stress, worsening the inflammation and pain experienced in gout. For example, in March 2022, the World Health Organization, a Switzerland-based United Nations agency dedicated to global public health, approximated that 1 billion people, made up of 650 million adults, 340 million adolescents, and 39 million kids, were classified as obese. This number continues to rise. Additionally, forecasts suggest that by 2025, about 167 million adults and children will experience health problems related to obesity. Consequently, the rising prevalence of obesity is stimulating the growth of the gouty arthritis market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16070&type=smp
#What is the Growth Potential of the Gouty Arthritis Market, and How Will It Perform by 2034?
The market size for gouty arthritis has witnessed substantial growth over the past few years. There’s a forecasted progression from $3.44 billion in 2024 to $3.7 billion in 2025, guided by a compound annual growth rate (CAGR) of 7.6%. Factors driving this upward trend during the historic period include the rampant chronic diseases, elevated alcohol consumption, increase in the aging population, broader approval of advanced regenerative therapies, and escalating healthcare expenditure.
In the upcoming years, the market size of gouty arthritis is predicted to witness a robust growth. The market is forecasted to reach $4.9 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.2%. The projected growth during such period is due to enhancements in healthcare infrastructure, rising obesity rates, augmenting incidences of gout, and growing consciousness among the population. Key trends anticipated during the forecast period include increasing demand for potent treatment alternatives, regenerative therapy, advances in technology, product introduction, and regulatory authorizations.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16070
How Are Market Trends and Innovations Revolutionizing theGouty Arthritis Industry in Recent Times?
Significant businesses in the gouty arthritis industry are amplifying their product innovation endeavors, with the goal of unveiling new products like cortrophin gel. This gel is essentially a repository corticotropin injection and a refined version of the adrenocorticotropic hormone (ACTH). It’s primarily used in treating several acute and autoimmune conditions, including gouty arthritis. For illustration, ANI Pharmaceuticals, a pharmaceutical corporation based in the United States, was awarded FDA approval in October 2023 for their new 1-mL vial size Purified Cortrophin Gel. This product is purposed for the supplementary treatment of specific patients suffering from abrupt flare-ups of gouty arthritis. Currently, Cortrophin Gel is the solitary FDA-sanctioned ACTH therapy suitable for treating patients enduring acute gouty arthritis flare-ups.
Which Key Market Players Are Shaping the Future and Growth of theGouty Arthritis Market?
Major companies operating in the gouty arthritis market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol Myers Squibb, AstraZeneca plc, Novartis International AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report
What Are the Core Segments of the Gouty Arthritis Market, and How Do They Contribute to Growth?
The gouty arthritis market covered in this report is segmented –
1) By Type: Acute Gouty Arthritis, Chronic Gouty Arthritis
2) By Treatment: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxidase Inhibitors, Uricosurics, Others Treatments
3) By Diagnosis: Joint Fluid Test, Blood Test, X-Ray Imaging, Ultrasound, Dual Energy Computed Tomography (CT) Scan, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Others Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Acute Gouty Arthritis: Monosodium Urate Crystals-Induced Acute Gout, Acute Gout Attack (Intermittent Flares), Severe Acute Gout With Joint Deformities
2) By Chronic Gouty Arthritis: Tophaceous Gout (Presence Of Uric Acid Deposits), Chronic Gout With Joint Damage, Chronic Gout With Renal Complications, Chronic Gout With Comorbidities (Hypertension, Diabetes)
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16070&type=smp
What Regions Are Dominating the Gouty Arthritis Market Growth?
North America was the largest region in the gouty arthritis market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the gouty arthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Gouty Arthritis Market 2025, By The Business Research Company:
Osteoarthritis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report
Rheumatoid Arthritis Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report
Arthritis Monoclonal Antibodies Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
